 |
|
 |
|
 |
||||||||||||||||||||
 |
||||||||||||||||||||||
|
About us
Currently the government pays more attention to the development of high technologies in medicine.Radiation diagnostics and therapy is a medical direction dynamically developing in the whole world. Its new technologies make it possible, for instance, to research and treat oncological diseases with application of isotopes with no radical surgery required. In Russia such direction still falls behind world growth indicators, but there has been a tendency to reduce such gap demonstrated within recent years... News
April 07, 2010
April 05, 2010
March 25, 2010
February 25, 2010
February 24, 2010
February 11, 2010
|
|
Brachytherapy - Historical BackgroundBrachytherapy was first applied in 1910, when D.Pasto and P.Degre inserted radium-226 capsules into the prostate gland through urethra. After that in 1917, in the USA B.Barringer inserted micro sources into the gland using needles. Then in 1930, R.Flocks et al. used radioactive gold as an implant. Revival of the prostate gland cancer brachytherapy started in 1970 due to development of the technology of retropubical open implantation of I-125 grains at the Memorial Hospital of New York. However, in open retropubical technology iodine grains were inserted manually, preventing from well distribution in the prostate gland: with excessive activity zones there were cold foci. In 1981 H.Holm and D.Gammelguard applied iodine-125 microsources implantation technology for prostate gland tissue under control of transrectal ultrasound scan (TRUS). Such method was first applied for biopsy and it was clear that it could be used for visualization of radioactive sources position in the prostate gland. This was the basis for new brachytherapy technology. |
|||||||||||
|
